Insilico Medicine
A clinical-stage AI drug discovery company accelerating the development of novel therapeutics for various diseases.
Rate
About
Insilico Medicine is a generative AI company focused on transforming drug discovery and development. They utilize proprietary AI platforms like PandaOmics and Chemistry42 to discover novel therapeutic targets and generate new molecular structures, aiming to extend healthy productive longevity.
Technology stack
detected 2026-06-22Est. monthly stack spend~$1,440/mo
Email
Google Workspace
Analytics
Google Analytics 4
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does Insilico Medicine do?
Insilico Medicine is a generative AI company focused on transforming drug discovery and development. They utilize proprietary AI platforms like PandaOmics and Chemistry42 to discover novel therapeutic targets and generate new molecular structures, aiming to extend healthy productive longevity.
Where is Insilico Medicine headquartered?
Insilico Medicine is headquartered in Hong Kong, China.
When was Insilico Medicine founded?
Insilico Medicine was founded in 2014.
What industry does Insilico Medicine operate in?
Insilico Medicine operates in Biotech, MedTech, Drug Discovery, AI Drug Discovery, Genomics, Clinical Trials.
How many employees does Insilico Medicine have?
Insilico Medicine has approximately 285 people on record.